Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cancer Pain to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cancer Pain to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Cancer Pain Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Cancer Pain 30
Apr 19, 2017: Kancera has applied for a clinical trial for KAND567 30
Clinical Trial Profile Snapshots 31
Appendix 266
Abbreviations 266
Definitions 266
Research Methodology 267
Secondary Research 267
About GlobalData 268
Contact Us 268
Source 268

List of Tables
Cancer Pain Therapeutics, Global, Clinical Trials by Region, 2017* 7
Cancer Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Cancer Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Cancer Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Cancer Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Cancer Pain Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Cancer Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 13
Cancer Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 14
Proportion of Cancer Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 15
Cancer Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Cancer Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Cancer Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 18
Cancer Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Cancer Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Cancer Pain Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Cancer Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Cancer Pain Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Cancer Pain Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Cancer Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Cancer Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
Cancer Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Cancer Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Cancer Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List of Figures
Cancer Pain Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Cancer Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Cancer Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Cancer Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Cancer Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Cancer Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Cancer Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 13
Cancer Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 14
Proportion of Cancer Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 15
Cancer Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Cancer Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Cancer Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 18
Cancer Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Cancer Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Cancer Pain Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Cancer Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Cancer Pain Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Cancer Pain Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Cancer Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Cancer Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
Cancer Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Cancer Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Cancer Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
GlobalData Methodology 267

Companies Mentioned
• Johnson & Johnson
• Mundipharma International Ltd
• Wockhardt Ltd
• Pfizer Inc
• GW Pharmaceuticals Plc
• Grunenthal GmbH
• Otsuka Holdings Co Ltd
• Takeda Pharmaceutical Company Ltd
• Teikoku Seiyaku Co Ltd
• Kyowa Hakko Kirin Co Ltd